ArticleHaematologica2020

Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia.

Phuong Vo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.